Holland Capital Invests in Curess
Amsterdam, June 20th, 2024 – Holland Capital participates in Curess, a leading organization in youth care focused on systemic family support. Through the collaboration with Holland Capital, further growth and development can be achieved.
Systemic Family Support
Curess offers specialized ambulatory youth care (such as intensive systemic guidance, ambulatory emergency help, perspective research, and co-parenting investigations) and focuses on strengthening families through practical and directly applicable assistance. Curess operates without waiting lists and can scale its operations up and down quickly, to deliver the desired care swiftly and with high quality. The organization achieves this by applying self-developed software that supports core processes (such as planning) and thus reduces administrative pressure.
Strategic Parntership
With this strategic partnership, Curess has found a partner to achieve its ambitious strategic goals.
Eddy de Bruin, CEO of Curess, states: “With the support of Holland Capital, we can realize our ambitions and help even more young people and families. With their expertise and resources, we are better equipped to significantly increase our impact in youth care. We are committed to providing the necessary support to families to learn to live together better, without waiting lists, through our dedicated professionals.”
Margot Engels, Healthcare Partner at Holland Capital, adds: “We are proud to add Curess to our portfolio. Curess provides crucial support to families in an innovative way, and we look forward to working together on their growth ambitions and further professionalization of their services. Our shared vision is to provide the best possible care and support.”
About Curess
With over 200 registered professionals, Curess offers specialized ambulatory youth care to young people and families to ensure they can live together better. By utilizing personal and innovative methods, Curess strives for a safe and supportive environment for children and their families. Curess is active in the regions of Twente, Midden-IJssel, Oost-Veluwe, Noord-Veluwe, Achterhoek, and Zuid-Drenthe
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of realizing growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare, Technology, and Agrifood-Tech sectors. They understand the dynamics and opportunities, and have an extensive network in these sectors.
The participation in Curess fits within Holland Capital’s strategy to invest in companies that contribute to societal challenges and create value for society. With this investment, Holland Capital takes an important step in further strengthening its portfolio within the healthcare sector.
cards PLM Solutions takes the first step in the buy-and-build strategy with the acquisition of Settels Savenije PLM Services
cards PLM Solutions takes the first step in the buy-and-build strategy with the acquisition of Settels Savenije PLM ServicesAmsterdam / Best, September 29, 2021 – cards PLM Solutions, Product Lifecycle Management (PLM) solutions provider, takes the next step in its...
Valori takes first step in buy-and-build strategy with acquisition of Omnext
Valori takes first step in buy-and-build strategy with acquisition of OmnextUtrecht/Amsterdam, July 8th 2021 – Valori takes a majority stake in Omnext, a leading international player in software code analysis. The joining of forces, made possible by Holland Capital,...
Xilloc raises growth financing from Holland Capital
Xilloc raises growth financing from Holland Capital Geleen/Amsterdam, July 2nd 2021 - Xilloc, a leading innovator and producer of medical implants and devices, has raised growth finance for its international expansion and product development from Holland Capital....
Yes We Can Healthcare Group joins forces with Holland Capital
Yes We Can Healthcare Group joins forces with Holland Capital Hilvarenbeek / Amsterdam, 1st of July 2021 – Holland Capital joins forces with Yes We Can Healthcare Group (YWCHG), a mental healthcare clinic for young people between 13 and 23 with addictions and...
Sirius Medical Establishes Highly Experienced Supervisory Board and Announces CEO Transition
Sirius Medical establishes highly experienced Supervisory Board and announces CEO transition Eindhoven, May 11th 2021 - Sirius Medical, a medical device start-up developing the next generation of tumor localization technology, today announced that medical device...
Digital R&D simulation software platform RheoCube attracts funding of 2 million USD for international expansion
Digital R&D simulation software platform RheoCube attracts funding of 2 million USD for international expansion Amsterdam, 17 February 2021 – Digital R&D simulation software platform RheoCube has attracted an investment of over 2 million USD. This funding...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl